Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News on Pharma

Top 3 Biotech Stocks with Breakout Potential

The biotech industry is well-positioned to witness significant growth due to technological advancements and government spending. Moreover, given the sector’s defensive nature, biotech stocks Amicus Therapeutics (FOLD), Corcept Therapeutics (CORT), and Harmony Biosciences (HRMY) might be solid buys in 2023. Read on.

StockNews.com

DCGI calls for bridging bio-tech interface to get out of generic mindset

The Hindu

One of UK's biggest 'Breaking Bad' labs flooded streets with drugs worth £10m a MONTH

John Keet invested profits from a career dealing cocaine, cannabis and amphetamines into building and managing the lab in Henley-in-Arden, a quaint market town in Warwickshire

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

Staff shortages force pharmacies to close for 100,000 hours in a year amid plans to give them more work

Exclusive: It comes as experts warn plans to move work from GPs to pharmacies will have ‘marginal’ impact on GP crisis

The Independent UK

3 Growth Stocks to Buy Now

As a slowdown in monetary policy tightening is paving its way, the possibility of a soft landing still stands. Therefore, it could be an ideal opportunity for investors to load up on some fundamentally sound growth stocks, Novartis (NVS), Daimler Truck Holding (DTRUY), and CPI Aerostructures (CVU). Read on….

StockNews.com

2 Most Promising Biotech Stocks to Buy

Given the breakthrough developments and government initiatives, the biotech industry is well-positioned to grow steadily. Therefore, fundamentally strong biotech stocks Amicus Therapeutics (FOLD) and POINT Biopharma (PNT) could be worth buying now. Read on.

StockNews.com

“I’m 78 and my youthful skin is all down to this £10 Boots anti-ageing serum”

The No7 anti-ageing serum is usually £34.95 and has been reduced to £10 as part of Boots' weekly £10 Tuesday offers

Chronicle Live

Read news from The Economist, FT, and more,
with one subscription

Pharmacies in England to offer prescriptions for seven conditions amid surgery crisis

Proposal is designed to free up 15m GP appointments over the next two years

The Guardian - UK

No. 1 Undervalued Stock in May

Leading healthcare company McKesson’s (MCK) stock looks undervalued at its current price and could be an excellent pick for value investors. Let’s look at some of MCK’s key metrics.

StockNews.com

Roadside drug testing could have gone ahead on time - Police Association

The Police Association says alternative policy could have been pushed through in order to enable roadside drug testing on time.

Newsroom.co.nz

Warning of more pharmacy closures ‘unless Government provides urgent funding’

Government proposals to improve access to primary care are expected on Tuesday.

The Independent UK

The Bottom of the Barrel: The Worst Drug Store Stock for Investors

MedAvail Holdings’ (MDVL) net loss widened by nearly 9% in fiscal 2022. The company has been taking some measures to achieve profitability, but it still looks far away. Amid this backdrop, investors could consider avoiding the stock. Read more….

StockNews.com

FDA weighing 1st over-the-counter birth control pill

U.S. health regulators are weighing the first-ever request to make a birth control pill available without a prescription

The Independent UK

Shield Therapeutics shareholders told to reject £46.1m takeover offer

One of the firm's long term shareholders has tabled an offer

Birmingham Post

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Explosion rips roof off pharmaceutical plant; worker missing

Officials say an explosion at a pharmaceutical plant in Massachusetts left one worker missing and sent four people to the hospital as a precaution

Birmingham Post

Drug testing venture Cansford Laboratories acquired by Phenna Group

Lexington Corporate Finance advised the shareholders of Cansford on the sale

Birmingham Post

Certus Biomedical relocates to meet growing demand with plans to double workforce

The Cornwall-based medical equipment service and supply company hopes to double its team in the next two years

Tom’s Hardware

AMD Says Delayed 7040HS 'Phoenix' Laptop CPUs Are Now Shipping to OEMs

AMD says that it has made its own self-imposed deadline to ship its Ryzen 7040HS laptop processors, also known as the "Phoenix" series, to OEMs.

Get all your
news in one place.

100's of premium titles.
One news app.

Wales Online

High Court hearing to begin over hormone pregnancy test blamed for birth defects

More than 200 people are launching a legal case after claiming to be caused harm by the drug Primodos, which was given to women to test if they were pregnant from the 1950s until the late 1970s

The Texas Tribune

Attorney General Ken Paxton to investigate COVID-19 vaccine makers

Long an opponent of vaccine and mask mandates, the Republican said pharmaceutical companies may have misrepresented data. Pfizer strongly disagrees.

The Times of India

Recruitment of drug inspectors: Karnataka HC directs govt to redo selection list

BENGALURU: Finding fault with the authorities with regards to insertion of “18 months experience clause” at a belated stage in the eligibility criteria pertaining to selection of Drug Inspectors, the Karnataka high court has quashed the entire selection list published in November 2020.

The Independent UK

Frustration grows over wait on OxyContin maker's settlement

More than a year after the maker of OxyContin reached a tentative settlement over the toll of opioids, the money isn't flowing yet

StockNews.com

Healthy Returns: This A Rated Healthcare Stock Is a Must-Watch for May

Given the pharmaceutical industry’s robust growth prospects, drug-maker Neurocrine Biosciences’ (NBIX) stock is worth watching ahead of its first-quarter earnings next week. Read on….

The Independent UK

Vermont passes bills aimed at protecting abortion pills

The Vermont Legislature has passed reproductive and gender-affirming health care bills with a late addition aimed at protecting access to a medication widely used in abortions — even if the U.S. Food and Drug Administration withdraws its approval of mifepristone

StockNews.com

A Prescription for Success: Check Out This Strong Pharmaceutical Stock This Week

Leading biotech company Regeneron Pharmaceuticals (REGN) has exhibited robust financial growth in recent years. With the biotech industry’s promising prospects, this stock might be a solid portfolio addition now. Read on….

1 … 52 53 54 55

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the European Commission

the London Stock Exchange

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.